202 related articles for article (PubMed ID: 24756113)
1. Apoptosis therapy in cancer: the first single-molecule co-activating p53 and the translocator protein in glioblastoma.
Daniele S; Taliani S; Da Pozzo E; Giacomelli C; Costa B; Trincavelli ML; Rossi L; La Pietra V; Barresi E; Carotenuto A; Limatola A; Lamberti A; Marinelli L; Novellino E; Da Settimo F; Martini C
Sci Rep; 2014 Apr; 4():4749. PubMed ID: 24756113
[TBL] [Abstract][Full Text] [Related]
2. Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells.
Daniele S; Barresi E; Zappelli E; Marinelli L; Novellino E; Da Settimo F; Taliani S; Trincavelli ML; Martini C
Oncotarget; 2016 Feb; 7(7):7866-84. PubMed ID: 26761214
[TBL] [Abstract][Full Text] [Related]
3. Lead Optimization of 2-Phenylindolylglyoxylyldipeptide Murine Double Minute (MDM)2/Translocator Protein (TSPO) Dual Inhibitors for the Treatment of Gliomas.
Daniele S; La Pietra V; Barresi E; Di Maro S; Da Pozzo E; Robello M; La Motta C; Cosconati S; Taliani S; Marinelli L; Novellino E; Martini C; Da Settimo F
J Med Chem; 2016 May; 59(10):4526-38. PubMed ID: 27050782
[TBL] [Abstract][Full Text] [Related]
4. Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
Costa B; Bendinelli S; Gabelloni P; Da Pozzo E; Daniele S; Scatena F; Vanacore R; Campiglia P; Bertamino A; Gomez-Monterrey I; Sorriento D; Del Giudice C; Iaccarino G; Novellino E; Martini C
PLoS One; 2013; 8(8):e72281. PubMed ID: 23977270
[TBL] [Abstract][Full Text] [Related]
5. Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells.
Daniele S; Costa B; Zappelli E; Da Pozzo E; Sestito S; Nesi G; Campiglia P; Marinelli L; Novellino E; Rapposelli S; Martini C
Sci Rep; 2015 Apr; 5():9956. PubMed ID: 25898313
[TBL] [Abstract][Full Text] [Related]
6. TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance.
Costa B; Da Pozzo E; Giacomelli C; Taliani S; Bendinelli S; Barresi E; Da Settimo F; Martini C
Apoptosis; 2015 Mar; 20(3):383-98. PubMed ID: 25413799
[TBL] [Abstract][Full Text] [Related]
7. A tryptophanol-derived oxazolopiperidone lactam is cytotoxic against tumors via inhibition of p53 interaction with murine double minute proteins.
Soares J; Raimundo L; Pereira NA; dos Santos DJ; Pérez M; Queiroz G; Leão M; Santos MM; Saraiva L
Pharmacol Res; 2015; 95-96():42-52. PubMed ID: 25814188
[TBL] [Abstract][Full Text] [Related]
8. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme.
Daniele S; La Pietra V; Piccarducci R; Pietrobono D; Cavallini C; D'Amore VM; Cerofolini L; Giuntini S; Russomanno P; Puxeddu M; Nalli M; Pedrini M; Fragai M; Luchinat C; Novellino E; Taliani S; La Regina G; Silvestri R; Martini C; Marinelli L
Eur J Pharmacol; 2021 Apr; 897():173936. PubMed ID: 33581134
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer.
Shangary S; Ding K; Qiu S; Nikolovska-Coleska Z; Bauer JA; Liu M; Wang G; Lu Y; McEachern D; Bernard D; Bradford CR; Carey TE; Wang S
Mol Cancer Ther; 2008 Jun; 7(6):1533-42. PubMed ID: 18566224
[TBL] [Abstract][Full Text] [Related]
10. A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.
Chen X; Tai L; Gao J; Qian J; Zhang M; Li B; Xie C; Lu L; Lu W; Lu W
J Control Release; 2015 Nov; 218():29-35. PubMed ID: 26428461
[TBL] [Abstract][Full Text] [Related]
11. TSPO as a target for glioblastoma therapeutics.
Werry EL; Barron ML; Kassiou M
Biochem Soc Trans; 2015 Aug; 43(4):531-6. PubMed ID: 26551689
[TBL] [Abstract][Full Text] [Related]
12. Dual targeting of MDM2 with a novel small-molecule inhibitor overcomes TRAIL resistance in cancer.
Singh AK; Chauhan SS; Singh SK; Verma VV; Singh A; Arya RK; Maheshwari S; Akhtar MS; Sarkar J; Rangnekar VM; Chauhan PMS; Datta D
Carcinogenesis; 2016 Nov; 37(11):1027-1040. PubMed ID: 27543608
[TBL] [Abstract][Full Text] [Related]
13. Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action.
Punganuru SR; Artula V; Zhao W; Rajaei M; Deokar H; Zhang R; Buolamwini JK; Srivenugopal KS; Wang W
Cells; 2020 Jul; 9(7):. PubMed ID: 32630235
[TBL] [Abstract][Full Text] [Related]
14. A Novel Platinum-Maurocalcine Conjugate Induces Apoptosis of Human Glioblastoma Cells by Acting through the ROS-ERK/AKT-p53 Pathway.
Aroui S; Dardevet L; Ben Ajmia W; de Boisvilliers M; Perrin F; Laajimi A; Boumendjel A; Kenani A; Muller JM; De Waard M
Mol Pharm; 2015 Dec; 12(12):4336-48. PubMed ID: 26465677
[TBL] [Abstract][Full Text] [Related]
15. Efficient reactivation of p53 in cancer cells by a dual MdmX/Mdm2 inhibitor.
Qin L; Yang F; Zhou C; Chen Y; Zhang H; Su Z
J Am Chem Soc; 2014 Dec; 136(52):18023-33. PubMed ID: 25453499
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategy.
Lu Y; Nikolovska-Coleska Z; Fang X; Gao W; Shangary S; Qiu S; Qin D; Wang S
J Med Chem; 2006 Jun; 49(13):3759-62. PubMed ID: 16789731
[TBL] [Abstract][Full Text] [Related]
17. Derivatives of the pyrazolo[1,5-a]pyrimidine acetamide DPA-713 as translocator protein (TSPO) ligands and pro-apoptotic agents in human glioblastoma.
Werry EL; King VA; Barron ML; Banister SD; Sokias R; Kassiou M
Eur J Pharm Sci; 2017 Jan; 96():186-192. PubMed ID: 27658888
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous Targeting of RGD-Integrins and Dual Murine Double Minute Proteins in Glioblastoma Multiforme.
Merlino F; Daniele S; La Pietra V; Di Maro S; Di Leva FS; Brancaccio D; Tomassi S; Giuntini S; Cerofolini L; Fragai M; Luchinat C; Reichart F; Cavallini C; Costa B; Piccarducci R; Taliani S; Da Settimo F; Martini C; Kessler H; Novellino E; Marinelli L
J Med Chem; 2018 Jun; 61(11):4791-4809. PubMed ID: 29775303
[TBL] [Abstract][Full Text] [Related]
19. MTBP regulates cell survival and therapeutic sensitivity in TP53 wildtype glioblastomas.
Song Y; Zhang L; Jiang Y; Hu T; Zhang D; Qiao Q; Wang R; Wang M; Han S
Theranostics; 2019; 9(20):6019-6030. PubMed ID: 31534534
[No Abstract] [Full Text] [Related]
20. Activation of p53 by nutlin-3a induces apoptosis and cellular senescence in human glioblastoma multiforme.
Villalonga-Planells R; Coll-Mulet L; Martínez-Soler F; Castaño E; Acebes JJ; Giménez-Bonafé P; Gil J; Tortosa A
PLoS One; 2011 Apr; 6(4):e18588. PubMed ID: 21483692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
